Effect of proprotein convertase subtilisin/kexin type 9 inhibitors on lipoprotein(a) still to be unravelled.

MLA

Sbrana, Francesco, et al. “Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a) Still to Be Unravelled.” European Journal of Preventive Cardiology, vol. 26, no. 7, May 2019, p. 782. EBSCOhost, https://doi.org/10.1177/2047487319825918.

APA

Sbrana, F., Dal Pino, B., Bigazzi, F., & Sampietro, T. (2019). Effect of proprotein convertase subtilisin/kexin type 9 inhibitors on lipoprotein(a) still to be unravelled. European Journal of Preventive Cardiology, 26(7), 782. https://doi.org/10.1177/2047487319825918

Chicago

Sbrana, Francesco, Beatrice Dal Pino, Federico Bigazzi, and Tiziana Sampietro. 2019. “Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Lipoprotein(a) Still to Be Unravelled.” European Journal of Preventive Cardiology 26 (7): 782. doi:10.1177/2047487319825918.